These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 30293231)

  • 21. A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer.
    Shore ND; Concepcion R; Barocas DA
    Hosp Pract (1995); 2013; 41(4):78-80. PubMed ID: 24145592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A urologic oncology roundtable discussion: issues to consider in choosing treatment for metastatic castration-resistant prostate cancer.
    Taplin ME; Berry WR; Casey AM; Aslo A
    Hosp Pract (1995); 2013; 41(4):81-2. PubMed ID: 24145593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3.
    Geethakumari PR; Cookson MS; Kelly WK;
    Oncology (Williston Park); 2016 Feb; 30(2):187-95, 199. PubMed ID: 26888794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Availability of Local Therapy to Castration-Resistant Prostate Cancer for M0 Patients with Initial Prostate Specific Antigen 100 ng/ml or Higher].
    Kuromoto A; Tanaka T; Koyama J; Goto T; Kimura S; Katsumata Y; Myoen S; Ozawa M; Morozumi K; Sato M; Hoshi S; Numahata K; Arai Y
    Hinyokika Kiyo; 2017 Dec; 63(12):515-520. PubMed ID: 29370662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Castration-Resistant Prostate Cancer: AUA Guideline Amendment 2018.
    Lowrance WT; Murad MH; Oh WK; Jarrard DF; Resnick MJ; Cookson MS
    J Urol; 2018 Dec; 200(6):1264-1272. PubMed ID: 30086276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metastatic castration-resistant prostate cancer (CRPC): preclinical and clinical evidence for the sequential use of novel therapeutics.
    Mukherji D; Omlin A; Pezaro C; Shamseddine A; de Bono J
    Cancer Metastasis Rev; 2014 Sep; 33(2-3):555-66. PubMed ID: 24452758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shifting paradigms in the estimation of survival for castration-resistant prostate cancer: A tertiary academic center experience.
    Afshar M; Evison F; James ND; Patel P
    Urol Oncol; 2015 Aug; 33(8):338.e1-7. PubMed ID: 26059077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient-derived Hormone-naive Prostate Cancer Xenograft Models Reveal Growth Factor Receptor Bound Protein 10 as an Androgen Receptor-repressed Gene Driving the Development of Castration-resistant Prostate Cancer.
    Hao J; Ci X; Xue H; Wu R; Dong X; Choi SYC; He H; Wang Y; Zhang F; Qu S; Zhang F; Haegert AM; Gout PW; Zoubeidi A; Collins C; Gleave ME; Lin D; Wang Y
    Eur Urol; 2018 Jun; 73(6):949-960. PubMed ID: 29544736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimizing the treatment of metastatic castration-resistant prostate cancer: a Latin America perspective.
    Sade JP; Báez CAV; Greco M; Martínez CH; Avitia MÁÁ; Palazzo C; Toriz NH; Trujillo PIB; Bastos DA; Schutz FA; Bella S; Nogueira L; Shore ND
    Med Oncol; 2018 Mar; 35(4):56. PubMed ID: 29556815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Castration-Resistant Prostate Cancer: Mechanisms, Targets and Treatment.
    Mansinho A; Macedo D; Fernandes I; Costa L
    Adv Exp Med Biol; 2018; 1096():117-133. PubMed ID: 30324351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Managed care implications in castration-resistant prostate cancer.
    Lew I
    Am J Manag Care; 2013 Dec; 19(18 Suppl):s376-81. PubMed ID: 24494692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Japanese Expert Panel Meeting on the Management of Prostate Cancer with Bone Metastases.
    Takahashi S; Kinuya S; Nonomura N; Shinohara N; Suzuki K; Suzuki H; Nakamura K; Satoh T; Tateishi U; Yoneda T; Horikoshi H; Igawa T; Kamai T; Koizumi M; Kosaka T; Matsubara N; Miyake H; Mizokami A; Mizowaki T; Nakamura N; Nozawa M; Takahashi T; Uemura H; Uemura M; Yokomizo A; Yoshimura M; Kakehi Y
    Oncol Ther; 2018 Dec; 6(2):157-171. PubMed ID: 32700033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021.
    Gillessen S; Armstrong A; Attard G; Beer TM; Beltran H; Bjartell A; Bossi A; Briganti A; Bristow RG; Bulbul M; Caffo O; Chi KN; Clarke CS; Clarke N; Davis ID; de Bono JS; Duran I; Eeles R; Efstathiou E; Efstathiou J; Ekeke ON; Evans CP; Fanti S; Feng FY; Fizazi K; Frydenberg M; George D; Gleave M; Halabi S; Heinrich D; Higano C; Hofman MS; Hussain M; James N; Jones R; Kanesvaran R; Khauli RB; Klotz L; Leibowitz R; Logothetis C; Maluf F; Millman R; Morgans AK; Morris MJ; Mottet N; Mrabti H; Murphy DG; Murthy V; Oh WK; Ost P; O'Sullivan JM; Padhani AR; Parker C; Poon DMC; Pritchard CC; Rabah DM; Rathkopf D; Reiter RE; Rubin M; Ryan CJ; Saad F; Sade JP; Sartor O; Scher HI; Shore N; Skoneczna I; Small E; Smith M; Soule H; Spratt DE; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Taplin ME; Tilki D; Tombal B; Türkeri L; Uemura H; Uemura H; van Oort I; Yamoah K; Ye D; Zapatero A; Omlin A
    Eur Urol; 2022 Jul; 82(1):115-141. PubMed ID: 35450732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of metastasis in castration-resistant prostate cancer patients: decision algorithm in imaging tests.
    Juárez-Soto A; Garín-Ferreira JM; Rodríguez-Fernández A; Tirado-Hospital JL; González-Serrano MT; Moreno-Jiménez J; Medina-López R; Baena-González V
    Actas Urol Esp (Engl Ed); 2019 Mar; 43(2):55-61. PubMed ID: 30082102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oligometastatic Prostate Cancer: Results of a Dutch Multidisciplinary Consensus Meeting.
    Aluwini SS; Mehra N; Lolkema MP; Oprea-Lager DE; Yakar D; Stoevelaar H; van der Poel H; ; Busstra M; de Jong IJ; de Reijke T; de Vries K; Heijmink S; Jenster G; Klaver S; Kneppers J; Lavalaye J; Leyten G; Moonen L; Nagaraj J; Noordzij W; Osanto S; Oving I; Schaake E; Scheenen T; Schoots I; Sedelaar M; Somford D; van den Berkmortel F; van der Hulle T; van der Voort van Zyp J; van Leeuwen P; van Moorselaar J; van Oort I; Vogel W; Westgeest H
    Eur Urol Oncol; 2020 Apr; 3(2):231-238. PubMed ID: 31401014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.
    Gillessen S; Attard G; Beer TM; Beltran H; Bossi A; Bristow R; Carver B; Castellano D; Chung BH; Clarke N; Daugaard G; Davis ID; de Bono J; Borges Dos Reis R; Drake CG; Eeles R; Efstathiou E; Evans CP; Fanti S; Feng F; Fizazi K; Frydenberg M; Gleave M; Halabi S; Heidenreich A; Higano CS; James N; Kantoff P; Kellokumpu-Lehtinen PL; Khauli RB; Kramer G; Logothetis C; Maluf F; Morgans AK; Morris MJ; Mottet N; Murthy V; Oh W; Ost P; Padhani AR; Parker C; Pritchard CC; Roach M; Rubin MA; Ryan C; Saad F; Sartor O; Scher H; Sella A; Shore N; Smith M; Soule H; Sternberg CN; Suzuki H; Sweeney C; Sydes MR; Tannock I; Tombal B; Valdagni R; Wiegel T; Omlin A
    Eur Urol; 2018 Feb; 73(2):178-211. PubMed ID: 28655541
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Definition and Diagnosis of Oligometastatic Bladder Cancer: A Delphi Consensus Study Endorsed by the European Association of Urology, European Society for Radiotherapy and Oncology, and European Society of Medical Oncology Genitourinary Faculty.
    Bamias A; Stenzl A; Brown SL; Albiges L; Babjuk M; Birtle A; Briganti A; Burger M; Choudhury A; Colecchia M; De Santis M; Fanti S; Fonteyne V; Gallucci M; Rivas JG; Huddart R; Junker K; Kroeze S; Loriot Y; Merseburger A; Montironi R; Necchi A; Oing C; Oldenburg J; Ost P; Pinkawa M; Ribal MJ; Rouprêt M; Thoeny H; Zilli T; Hoskin P
    Eur Urol; 2023 Oct; 84(4):381-389. PubMed ID: 37217391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chinese Expert Consensus on the Diagnosis and Treatment of Castration-Resistant Prostate Cancer (2019 Update).
    Zhu Y; Ye D;
    Cancer Manag Res; 2020; 12():2127-2140. PubMed ID: 32273753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Updated treatments of castration-resistant prostate cancer].
    Wei YF; Gu XJ; Zhu QY
    Zhonghua Nan Ke Xue; 2016 May; 22(5):455-61. PubMed ID: 27416673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
    Bonet M; González D; Baquedano JE; García E; Altabas M; Casas F; Feltes N; Ferrer F; Foro P; Fuentes R; Galdeano M; Gomez D; Henriquez I; Jové J; Lozano J; Maldonado X; Mases J; Membrive I; Paredes S; Roselló À; Sancho G; Mira M
    Clin Transl Oncol; 2023 Apr; 25(4):1017-1023. PubMed ID: 36436177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.